Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
GSE supplementation significantly reduced diastolic blood pressure (DBP) and heart rate (HR), though no significant effects were found for systolic blood pressure (SBP) or flow-mediated dilation (FMD) [PMID:34798267].
Supplementation (300 mg/day) led to significantly higher reductions in body weight, BMI, waist circumference, and waist-to-hip ratio compared to placebo [PMID:31713941].
GSE supplementation (250 mg proanthocyanidins) resulted in greater reductions in IL-6 and MDA compared to placebo [PMID:38419408].
Evidence suggests GSE may significantly lower total and low-density lipoprotein (LDL) cholesterol levels after four weeks [PMID:34067538].
Clinical evidence for the modulation of glycation markers, such as glycated hemoglobin, is limited and was not affected in the reviewed studies [PMID:34369228].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 39796507 (2024) — Effect of Proanthocyanidins from Grape Seed Extract on Benign Prostatic Hyperplasia. · Nutrients
- 2.PMID: 32180617 (2020) — Grape seed extract: having a potential health benefits. · Journal of food science and technology
- 3.PMID: 32992712 (2020) — Grape (Vitis vinifera L.) Seed Oil: A Functional Food from the Winemaking Industry. · Foods (Basel, Switzerland)
- 4.PMID: 34798267 (2022) — The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: A systematic review and meta-analysis of controlled trials with duration- and dose-response analysis. · Pharmacological research
- 5.PMID: 38111186 (2024)